The Role of Daily Disposable Contact Lenses in Ocular Allergy

This study has been completed.
Sponsor:
Collaborator:
National Pollen and Aerobiology Unit, Worcester
Information provided by:
Aston University
ClinicalTrials.gov Identifier:
NCT01125540
First received: May 17, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted
  Purpose

Patients with seasonal allergic conjunctivitis are normally advised to avoid contact lens wear when they are having symptoms. However, modern soft contact lenses which are disposed of daily offer the potential to protect and lubricate the ocular surface. This study examines this possible effect.


Condition Intervention
Grass Pollen Ocular Allergy
Device: Acuvue (Standard Daily Disposable Contact Lens)
Device: CIBA Dailies Aquacomfort Plus (Contact Lens - enhance lubricating)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Prevention
Official Title: The Role of Daily Disposable Contact Lenses in Ocular Allergy

Resource links provided by NLM:


Further study details as provided by Aston University:

Primary Outcome Measures:
  • Symptoms [ Time Frame: 4 hours ] [ Designated as safety issue: No ]
    Subjective rating of itchyness, dryness, burning, watering and discomfort

  • Signs [ Time Frame: 4 hours ] [ Designated as safety issue: No ]
    Signs of bulbar, limbal and palpebtal hyperaemia and staining


Enrollment: 10
Study Start Date: June 2007
Study Completion Date: January 2010
Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Acuvue (Standard Daily Disposable Contact Lens)
    Other Name: Acuvue
    Device: CIBA Dailies Aquacomfort Plus (Contact Lens - enhance lubricating)
    Other Name: CIBA Dailies Aquacomfort Plus
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • contact lens wearer
  • proven allergy to grass pollen

Exclusion Criteria:

  • eye disease
  • ocular medication
  • allergy medication
  • asthma
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01125540

Locations
United Kingdom
Aston University
Birmingham, West Midlands, United Kingdom, B4 7ET
Sponsors and Collaborators
Aston University
National Pollen and Aerobiology Unit, Worcester
  More Information

No publications provided

Responsible Party: Prof James Wolffsohn, Aston University
ClinicalTrials.gov Identifier: NCT01125540     History of Changes
Other Study ID Numbers: Allergy02
Study First Received: May 17, 2010
Last Updated: May 17, 2010
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by Aston University:
Allergic conjunctivitis

Additional relevant MeSH terms:
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on August 28, 2014